Open AccessBevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial
Author(s) -
Andrés Poveda,
Frédèric Selle,
Felix Hilpert,
Alexander Reuß,
Antonella Savarese,
Ignace Vergote,
Petronella O. Witteveen,
Aristotelis Bamias,
Nana Scotto,
Lada Mitchell,
Éric Pujade-Lauraine
Publication year - 2015
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2015.63.1408
Subject(s) - topotecan , medicine , paclitaxel , ovarian cancer , oncology , bevacizumab , chemotherapy , doxorubicin , randomized controlled trial , cohort , pharmacology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom